1 Min Read
Aug 4 (Reuters) - Rosetta Genomics Ltd
* Rosetta genomics says priced public offering of 1.95 million units at effective purchase price of $1.40 per unit Source text for Eikon: (bit.ly/2v54Dy2) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.